The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Observational)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorFederal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health

About this trial

The study is aimed at the investigation of the association of biomarkers of circadian rhythms with sleep characteristics and stroke outcome in acute stroke patients. It is designed as an observational cohort study with the retrospective and prospective longitudinal arms.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

acute (symptom onset to admission <1 days) ischemic stroke

ischemic stroke affecting the branches of anterior cerebral artery, middle cerebral artery and posterior cerebral artery

age 18-80 years

moderate or severe stroke (National Institutes of Health Stroke Scale, NIHSS>=5)

Disqualifiers

secondary parenchymal hemorrhage (>hemorrhage index -2)

clinically unstable or life-threatening conditions

known progressive neurological diseases

known psychiatric diseases

Trial population

Participants will be recruited from the patients with confirmed acute ischemic stroke admitted to the Stroke Unit

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

  • No intervention is planned

    Other intervention

    No intervention is planned

Treatment groups

250 Participants
are divided into 2 treatment groups
Group A: Retrospective cohort1 intervention
Group B: Prospective cohort1 intervention

Trial outcomes

Primary outcomes

1

Change in the value of National Institutes of Health Stroke Scale from baseline to 14th day after inclusion

National Institutes of Health Stroke Scale (NIHSS) is a tool used to objectively quantify the impairment caused by a stroke, 0-42 scores, higher scores characterize worse impairment

Time frame
From baseline to 14th day after treatment initiation
2

Stroke-related disability assessed by the change in modified Rankin scale from baseline to 14th day after treatment initiation

values of modified Rankin scale (scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke, from 0 (no symptoms) to 6 (dead) points)

Time frame
From baseline to 14th day after treatment initiation
3

Stroke-related disability assessed by the change in Rivermead Mobility Index from baseline to 14th day after treatment initiation

a standardized scale used to assess mobility in patients with neurological deficits, a maximum of 15 points is possible; higher scores indicate better mobility performance

Time frame
From baseline to 14th day after treatment initiation
4

Stroke-related disability assessed by the change in Barthel Index from baseline to 14th day after treatment initiation

a common scale used to measure performance in activities of daily living, 0-100 scores, higher scores define better performance

Time frame
From baseline to 14th day after treatment initiation

Secondary outcomes

1

Sleep quality assessed by Pittsburgh Sleep Quality Index

Pittsburgh Sleep Quality Index is a self-rated questionnaire which assesses sleep quality and disturbances over the last (previous) 1-month (a retrospective assessment) time interval, Each of the sleep components yields a score ranging from 0 to 3, with 3 indicating the greatest dysfunction. The sleep component scores are summed to yield a total score ranging from 0 to 21 with the higher total score indicating worse sleep quality

Time frame
Baseline
2

Sleepiness assessed by Epworth Sleepiness Scale

a common tool to assess sleepiness; 0-24 points, higher score indicate greater sleepiness

Time frame
Baseline
3

Fatigue assessed by Fatigue severity Scale

a common 9-item tool used to determine and quantify fatigue as subjective feeling of exhaustion, persisting lack of energy and rapid inanition, 9-63 points, higher score indicates more severe fatigue

Time frame
Baseline
4

Insomnia assessed by Insomnia severity index

a 7-item tool to assess the severity of insomnia, 0-5 points per each item, higher score indicates more severe insomnia

Time frame
Baseline

Other outcomes

1

sleep-related respiratory characteristics: apnea-hypopnea index

assessed by routine polygraphy: apnea-hypopnea index (higher values indicate greater severity; \<5 episodes/h - normal, \>=5 episodes/h - pathological)

Time frame
Baseline
2

sleep-related respiratory characteristics: oxygen desaturation index

assessed by routine polygraphy: oxygen desaturation index (higher values indicate greater severity; \<5 episodes/h - normal, \>=5 episodes/h - pathological)

Time frame
Baseline
3

sleep-related respiratory characteristics: time under oxygen saturation <90%

assessed by routine polygraphy: time under oxygen saturation \<90% (higher values indicate greater severity), in minutes

Time frame
Baseline
4

sleep-related respiratory characteristics: average oxygen saturation

assessed by routine polygraphy: average oxygen saturation (lower values indicate greater severity), in %

Time frame
Baseline